INLB - Item 9 Labs Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
4.3000
-0.5850 (-11.98%)
As of 9:51AM EST. Market open.
Stock chart is not supported by your current browser
Previous Close4.8850
Open4.3000
Bid0.00 x 0
Ask0.00 x 0
Day's Range4.3000 - 4.3000
52 Week Range0.0800 - 8.4000
Volume367
Avg. Volume3,223
Market Cap256.836M
Beta (3Y Monthly)3.32
PE Ratio (TTM)N/A
EPS (TTM)-1.19
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire2 days ago

    Item 9 Labs Strengthens Executive Team

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced Chris Wolven is joining the executive team as Chief Operating Officer. Wolven previously served as Brand Chef at Fox Restaurant Concepts, a culinary powerhouse renowned for its boutique brands and thoughtfully curated dining experiences.  The group has an impressive lineup of more than 50 restaurant locations throughout the nation.

  • GlobeNewswire9 days ago

    Item 9 Labs Corp Broadens National Footprint Announces Joint Venture With Strive Wellness of Nevada

    Arizona-based Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), today announced a joint venture with Strive Wellness of Nevada, LLC (Strive Wellness), to construct and manage the 20,000 square-foot medical marijuana cultivation and processing facility in Pahrump, Nevada. Strive Wellness was approved for a medical marijuana license in April and received its Special Use Permit (SUP) in December 2018. Strive Wellness is estimated to be producing legal medical marijuana products in the next nine months.

  • GlobeNewswire15 days ago

    Item 9 Labs Corp. CEO Sara Gullickson Recognized as Influential Cannabis Leader Named Among Women to Watch in 2019

    Sara Gullickson, CEO of Item 9 Labs Corp. (INLB), recently was selected by Marijuana Business Magazine for its Women to Watch in 2019 list. Gullickson was highlighted as an intrepid entrepreneur who established her own cannabis consulting firm Dispensary Permits at age 26. In her Women to Watch interview, Gullickson provided advice for those interested in entering the market, “Slow and steady wins the race.

  • GlobeNewswire28 days ago

    Item 9 Labs Corp Appoints Andrew Bowden to Board of Directors

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, recently announced the appointment of Andrew Bowden, co-founder and CEO of Bowden Investment Group, to its Board of Directors. The capital will support the planned geographic expansion of the Company in Arizona and Nevada as it advances its cannabis industry presence.

  • GlobeNewswirelast month

    Item 9 Labs Nears Completion of 10,000 Square-Foot Cultivation Facility for Next Phase of Broader Expansion Plan

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced the commencement of the second phase of its national expansion plan. The Company is further enhancing its Arizona cultivation and processing facility to include a commercial kitchen for infusion processes and expanded its site by an additional 10,000 square-feet. “The expansion is a natural evolution for Item 9 Labs as we continue to develop distinctive and organic cannabis solutions for wellbeing.

  • GlobeNewswirelast month

    Sara Gullickson Named First Woman CEO of a U.S. Publicly Traded Cannabis Company Item 9 Labs Corp.

    Award-winning international cannabis consultant Sara Gullickson was recently named CEO of Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms. The appointment is of historic significance, establishing Gullickson as the first woman CEO of a U.S. publicly traded cannabis company. Gullickson formerly served as CEO and Founder of Dispensary Permits, which was acquired by Item 9 Labs on November 26, 2018.

  • GlobeNewswire2 months ago

    Item 9 Labs Corp. Closes Acquisition of Arizona DP Consulting Assets and DispensaryPermits.com

    Item 9 Labs Corp. (INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and proprietary delivery platforms, today announced that on November 26, 2018, through its wholly owned subsidiary AZ DP Holdings, LLC, a Nevada limited liability company, that it closed on an Asset Purchase Agreement (the “Agreement”) with Arizona DP Consulting, LLC (“Dispensary Permits”) and its owner and founder Sara Gullickson, an award-winning international cannabis consultant with licensing success in over a dozen markets. Pursuant to the Agreement, the Company acquired the assets of Dispensary Permits, a nationally recognized cannabis consulting company specializing in helping entrepreneurs and industry stakeholders obtain cannabis licenses and build successful businesses.

  • GlobeNewswire2 months ago

    Item 9 Labs Corp. Secures $7.7 million for Geographic Expansion Plans

    SCOTTSDALE, Ariz., Nov. 20, 2018 -- Item 9 Labs Corp. (OTC: INLB) (Item 9 Labs or the Company), a leading developer and manufacturer of innovative cannabis products and.